Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program

NCT00969865 is registered in ClinicalTrials.gov with Piedmont Healthcare as lead sponsor.

NCT NCT00969865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00969865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program
Lead sponsor
Piedmont Healthcare
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
December 31, 2016
Enrollment
170 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis